Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology.
Shownotes:
Get in touch with the Sixfold team: Sixfold Bioscience; George Foot; Anna Perdrix
Interested in joining the team? Check out open roles here
In this episode, we cover:
Sixfold Bioscience and challenges with RNA delivery
How George and Anna started Sixfold
Switching between an academia and entrepreneurship mindset
Building a biotech totally from scratch
Twitter debate—founder led bio vs venture incubation
Building a diverse (majority women!) team and tips for recruitment
Sixfold's big vision
Broader trends to be excited about in biotech and deep tech
